Knowledge management and efficiency gains

In the face of escalating research and development (R&D) costs, currently estimated at $800 million US to produce a new drug, the life science discovery industry is constantly searching for ways to control expenditure, increase productivity and meet ever stricter compliance imposed by regulatory bodies.

One promising strategy for the drug discovery industry is to examine how maximum value can be extracted from a life sciences organization’s primary asset - knowledge.